Search Results 11-20 of 16606 for hidradenitis
A Study to Assess Disease Activity and Safety of Subcutaneous Lutikizumab (ABT-981) in Adult Participants With Moderate to Severe Hidradenitis Suppurativa ...
A Study Investigating Long-term Treatment With Spesolimab in People With a Skin Disease Called Hidradenitis Suppurativa Who Completed a Previous Clinical Trial.
A Study to Evaluate the Safety and Effectiveness of PF-06650833, PF-06700841, and PF 06826647 in Adults With Hidradenitis Suppurativa Evaluating the Safety ...
Hidradenitis suppurativa · Hidradenitis suppurativa and biologics: Get the facts · Hidradenitis suppurativa and diet: What's recommended? Hidradenitis ...
A Study to Assess Change in Disease Activity and Adverse Events of Oral Upadacitinib in Adult and Adolescent Participants With Moderate to Severe Hidradenitis ...
Guselkumab for the treatment of patients with moderate-to-severe hidradenitis suppurativa: A phase 2 randomized study. J Eur Acad Dermatol Venereol. 2023 Oct; ...
The purpose of this study is to focus on the interaction between stress hormones and mast cells (MCs in lesional skin of Hidradenitis Suppurativa (HS) patients.
The purpose of this study is to assess the effectivess and safety of Spesolimab in Hidradenitis Suppurativa (HS) patients. Participation eligibility.
At Mayo Clinic, Afsaneh Alavi, M.D., conducts dermatologic research in wound healing and inflammatory disorders of the skin such as hidradenitis suppurativa ...
Afsaneh Alavi, M.D., is a Professor of Dermatology in Rochester, Minnesota, with a special interest in inflammatory disorders including psoriasis, hidradenitis ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your GivingTuesday gift can go 2X as far.